BRIEF-Cadila Healthcare says FDA does not issue observation (483) to co's Moraiya unit

Last Updated: Thu, Feb 16, 2017 15:00 hrs

Feb 16 (Reuters) - Cadila Healthcare Ltd

* The USFDA inspected company's moraiya facility from February 6, 2017 to February 15, 2017.

* Says at the end of the inspection, no observation (483) is issued. Source text: http://bit.ly/2kMMsam Further company coverage:

More from Sify: